Gene, Cell and Tissue

Published by: Kowsar

Arginase - 1 - Based Diagnosis as Indicator of the Risk of HBV - Related HCC

Bita Moudi 1 , 2 , *
Author Information
1 Infectious Diseases and Tropical Medicine Research Center, Zahedan University of Medical Sciences, Zahedan, Iran
2 Department of Histology, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran
Article information
  • Gene, Cell and Tissue: January 2018, 5 (1); e79725
  • Published Online: December 30, 2017
  • Article Type: Letter
  • Received: April 2, 2017
  • Accepted: April 25, 2017
  • DOI: 10.5812/gct.79725

To Cite: Moudi B. Arginase - 1 - Based Diagnosis as Indicator of the Risk of HBV - Related HCC, Gene Cell Tissue. 2018 ; 5(1):e79725. doi: 10.5812/gct.79725.

Copyright © 2018, Gene, Cell and Tissue. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
References
  • 1. Moudi B, Heidari Z, Mahmoudzadeh-Sagheb H, Alavian SM, Lankarani KB, Farrokh P, et al. Concomitant use of heat-shock protein 70, glutamine synthetase and glypican-3 is useful in diagnosis of HBV-related hepatocellular carcinoma with higher specificity and sensitivity. Eur J Histochem. 2018;62(1):2859. doi: 10.4081/ejh.2018.2859. [PubMed: 29569872]. [PubMed Central: PMC5806503].
  • 2. Li H, Wang S, Wang G, Zhang Z, Wu X, Zhang T, et al. Yes-associated protein expression is a predictive marker for recurrence of hepatocellular carcinoma after liver transplantation. Dig Surg. 2014;31(6):468-78. doi: 10.1159/000370252. [PubMed: 25632982].
  • 3. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132(7):2557-76. doi: 10.1053/j.gastro.2007.04.061. [PubMed: 17570226].
  • 4. Moudi B, Heidari Z, Mahmoudzadeh-Sagheb H. Impact of host gene polymorphisms on susceptibility to chronic hepatitis B virus infection. Infect Genet Evol. 2016;44:94-105. doi: 10.1016/j.meegid.2016.06.043. [PubMed: 27346643].
  • 5. Tawada A, Kanda T, Yokosuka O. Current and future directions for treating hepatitis B virus infection. World J Hepatol. 2015;7(11):1541-52. doi: 10.4254/wjh.v7.i11.1541. [PubMed: 26085913]. [PubMed Central: PMC4462692].
  • 6. Sekine S, Ogawa R, McManus MT, Kanai Y, Hebrok M. Dicer is required for proper liver zonation. J Pathol. 2009;219(3):365-72. doi: 10.1002/path.2606. [PubMed: 19718708].
  • 7. Multhaupt H, Fritz P, Schumacher K. Immunohistochemical localisation of arginase in human liver using monoclonal antibodies against human liver arginase. Histochemistry. 1987;87(5):465-70. [PubMed: 3323144].
  • 8. Chrzanowska A, Gajewska B, Baranczyk-Kuzma A. Arginase isoenzymes in human cirrhotic liver. Acta Biochim Pol. 2009;56(3):465-9. [PubMed: 19636440].
  • 9. Yan BC, Gong C, Song J, Krausz T, Tretiakova M, Hyjek E, et al. Arginase-1: a new immunohistochemical marker of hepatocytes and hepatocellular neoplasms. Am J Surg Pathol. 2010;34(8):1147-54. doi: 10.1097/PAS.0b013e3181e5dffa. [PubMed: 20661013]. [PubMed Central: PMC3160135].
  • 10. Timek DT, Shi J, Liu H, Lin F. Arginase-1, HepPar-1, and Glypican-3 are the most effective panel of markers in distinguishing hepatocellular carcinoma from metastatic tumor on fine-needle aspiration specimens. Am J Clin Pathol. 2012;138(2):203-10. doi: 10.1309/AJCPK1ZC9WNHCCMU. [PubMed: 22904131].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments